Clinical Trials on Neoplasms, Second Primary in United States

Total 64686 results

Northwestern University
Merck Sharp & Dohme LLC

Recruiting

An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy

HIV Infections | Primary Health Care | Electronic Health Record

United States
University of California, Irvine
BTG International Inc.

Approved for marketing

TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma (TheraSphere)

Hepatocellular Carcinoma | Primary Liver Cancer | Liver Neoplasm | Liver Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Withdrawn

Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin

Carcinoma of Unknown Primary

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

Primary Brain Neoplasm

United States
Kenneth K. Tanabe, MD
National Cancer Institute (NCI)

Terminated

rRp450-Phase I Trial in Liver Metastases and Primary Liver Tumors

Liver Metastases | Primary Liver Cancers

United States
National Cancer Institute (NCI)

Terminated

Biomarker Analysis of Central Nervous System Tumors

Central Nervous System Neoplasms | Brain Cancer | Neoplasms, Brain | Primary Brain Neoplasms | Cancer of the Brain

United States
The Cleveland Clinic

Completed

Impact of Perioperative Intravenous Fluid Utilization on Postoperative Outcomes

Benign Neoplasm of Intestinal Tract | Primary Malignant Neoplasm of Intestinal Tract | Secondary Malignant Neoplasm of Intestinal Tract

United States
Arrowhead Regional Medical Center

Completed

Low Dose Vitamin C in Burns >20% Compared to Previous Studies With High Dose Vitamin C

Burns | Ascorbic Acid Deficiency | Fluid and Electrolyte Imbalance | Burn Degree Second | Burn Degree Third | Burn Shock

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors

Neuroendocrine Neoplasm | Multiple Endocrine Neoplasia Type 1 | Advanced Carcinoid Tumor | Digestive System Neuroendocrine Neoplasm | Unresectable Carcinoid Tumor

United States
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

Malignant Central Nervous System Neoplasm | Primary Central Nervous System Neoplasm

United States
Millennium Pharmaceuticals, Inc.

Terminated

A Study of MLN8054 in Patients With Advanced Solid Tumors

Breast Neoplasm | Pancreatic Neoplasm | Colon Neoplasm | Bladder Neoplasm

United States
Women and Infants Hospital of Rhode Island

Unknown

Passive Descent in Obese Nulliparous Gravidae

Management of the Second Stage of Labor in Obese Nulliparous Women by Either Passive Descent or Immediate Pushing.

United States
The Cleveland Clinic

Completed

Standard Medication Reconciliation Protocol in the Primary Care Office-based Setting

Medication Reconciliation Between Patients' Self Report and Electronic Medical Record List

United States
National Cancer Institute (NCI)

Active, not recruiting

Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma

Primary Effusion Lymphoma | B-Cell Neoplasm

United States
St. Jude Children's Research Hospital

Completed

Radiofrequency Ablation of Tumors

Metastatic Tumors | Primary Tumors

United States
Beth Israel Deaconess Medical Center

Terminated

Randomized Study of Stereotactic Body Radiotherapy vs. Conventional Radiation for Spine Metastasis

Metastatic Cancer | Primary Tumor

United States
National Cancer Institute (NCI)

Completed

Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
National Cancer Institute (NCI)

Completed

Oxaliplatin in Treating Patients With Liver Cancer

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
Genzyme, a Sanofi Company

Completed

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.

Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line

United States, Czech Republic, Hungary
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.

Lung Cancer | Carcinoma of Unknown Primary

United States
National Cancer Institute (NCI)

Completed

Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer

Fallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Neoplasm

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Cutaneous Melanoma | Recurrent Malignant Female Reproductive System Neoplasm | Refractory Malignant Female Reproductive System Neoplasm | Recurrent Lip and Oral Cavity Carcinoma | Recurrent Malignant Endocrine... and other conditions

United States
Innate Pharma

Completed

Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse (KIRIMID)

Patients With Multiple Myeloma Experiencing a | First or Second Relapse

United States
Delcath Systems Inc.

Unknown

Registry Protocol- Melphalan Percutaneous Hepatic Perfusion for the Treatment of Unresectable Hepatic Malignancy

Hepatic Malignant Neoplasm Primary Non-Resectable

United Kingdom
Fox Chase Cancer Center
Bristol-Myers Squibb

Completed

Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer

Urologic Neoplasm

United States
Novartis Pharmaceuticals

Completed

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients (MACS1295)

First or Second Line HER2-negative Breast Cancer | Metastatic Disease Without Bone Metastasis

United States
Excel Diagnostics and Nuclear Oncology Center

Withdrawn

Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. (PUTNET)

Neuroendocrine Tumors | Pheochromocytoma | Paraganglioma | Unknown Primary Tumors | Pulmonary Neuroendocrine Neoplasm | Thymus Carcinoid | Neuroendocrine Skin Carcinoma | Neuroendocrine Breast Tumor | Neuroendocrine Carcinoma Metastatic | Neuroendocrine Neoplasm of Ovary

United States
National Cancer Institute (NCI)

Completed

Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Microbial Diversity Between Inflamed and Non-inflamed Skin of Patients With Immune Checkpoint Inhibitor-Induced Dermatitis

Genito-Urinary Neoplasm

United States
National Institute of Diabetes and Digestive and...

Recruiting

Natural History Study of Parathyroid Disorders

Primary Hyperparathyroidism | Pseudohypoparathyroidism | Parathyroid Cancer | Inheritable Bone Diseases | Multiple Endocrine Neoplasia, Type 1

United States
National Cancer Institute (NCI)

Completed

A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer

Prostatic Neoplasm

United States
Emory University
National Cancer Institute (NCI)

Recruiting

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Hypogonadism | Malignant Urinary System Neoplasm | Urinary System Disorder | Urinary System Neoplasm

United States
National Cancer Institute (NCI)

Terminated

AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
National Cancer Institute (NCI)

Completed

IMC-A12 in Treating Patients With Advanced Liver Cancer

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
National Cancer Institute (NCI)

Completed

Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
Abramson Cancer Center of the University of Pennsylvania
Ovarian Cancer Research Center

Terminated

Autologous OC-L Vaccine and Ovarian Cancer

Fallopian Tube Cancer | Primary Peritoneal Cancer | Primary Ovarian Cancer

United States
M.D. Anderson Cancer Center
Pharmacia; LifeCell

Completed

rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin

Neoplasms, Gynecologic

United States
National Cancer Institute (NCI)

Completed

Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
Memorial Sloan Kettering Cancer Center
Genentech, Inc.

Completed

Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary PERITONEUM

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors

Brain Cancer | Brain Neoplasm | Brain Tumor, Primary

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia

Anemia | Myelofibrosis | Myelodysplastic/Myeloproliferative Neoplasm

United States
Johns Hopkins University
National Comprehensive Cancer Network

Recruiting

The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry (DISSRM)

Kidney Neoplasm

United States
University of Washington
National Cancer Institute (NCI)

Completed

Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant

Advanced Adult Primary Liver Cancer | Localized Resectable Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
University of Virginia
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States
Weill Medical College of Cornell University
New York State Department of Health

Completed

Assessing the Impact of Health Information Exchange (HIE) on Healthcare Utilization (VHR)

Health Care Utilization | Health Information Technology | Health Information Exchange | Virtual Health Record

United States
National Cancer Institute (NCI)

Completed

AMG 386 and Abiraterone for Advanced Prostate Cancer

Prostatic Neoplasms | Prostate Cancer | Neoplasm, Prostate | Neoplasm,Prostatic

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

3-Tesla MRI Response to TACE in HCC (Liver Cancer)

Advanced Adult Primary Liver Cancer | Localized Resectable Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma | Stage A Adult Primary Liver Cancer (BCLC) | Stage B Adult Primary Liver Cancer (BCLC)

United States
Advocate Health Care

Terminated

Does Less Trendelenburg Make a Difference in Robotic Assisted Gynecological Procedures?

Benign Female Reproductive System Neoplasm

United States
M.D. Anderson Cancer Center

Withdrawn

The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms

Malignant Neoplasms of Independent (Primary) Multiple Sites

United States
University of Texas Southwestern Medical Center
National Cancer Institute (NCI)

Recruiting

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Unknown Primary Cancer

United States

Clinical Trials on Neoplasms, Second Primary in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations